Spore.Bio Advances With $23M Series A Funding Led by Localglobe

Spore.Bio, a pioneer in light-powered microbiology testing, has secured $23 million in Series A funding led by Localglobe. The company's technology promises a significant advancement in safety testing across industries by delivering rapid insights within minutes, potentially saving lives. Already demonstrating success with accuracy comparable to traditional methods, Spore.Bio has entered into a partnership with the Pasteur Institute, acquired a local competitor, and has over 200 factories poised to implement its technology. This funding will help further their mission of improving food safety and public health on a global scale. The founders, Amine Raji, Maxime Mistretta, and Mohamed Tazi, are leading a multidisciplinary team that is set to make substantial contributions to the field. The investment also marks an important milestone for Europe's microbiology sector, particularly in France.